BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17404580)

  • 21. [Beta-blocker therapy for chronic heart failure in patients with dilated cardiomyopathy].
    Hori M; Kagiya T; Sato H; Kitabatake A
    Kokyu To Junkan; 1990 Dec; 38(12):1203-9. PubMed ID: 1981100
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients.
    Spinarová L; Spinar J; Vasků A; Pávková-Goldbergová M; Ludka O; Tomandl J; Vítovec J
    Exp Mol Pathol; 2008 Jun; 84(3):251-5. PubMed ID: 18442814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias.
    Ulucan C; Cetintas V; Tetik A; Eroglu Z; Kayikcioglu M; Can LH; Payzin S; Aydin M; Hasdemir C
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1053-8. PubMed ID: 18479335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade.
    Filigheddu F; Reid JE; Troffa C; PinnaParpaglia P; Argiolas G; Testa A; Skolnick M; Glorioso N
    Pharmacogenomics J; 2004; 4(3):154-60. PubMed ID: 15069461
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains.
    Vargas-Alarcón G; Fragoso JM; Cruz-Robles D; Vargas A; Martinez A; Lao-Villadóniga JI; García-Fructuoso F; Vallejo M; Martínez-Lavín M
    Arthritis Rheum; 2009 Jul; 60(7):2169-73. PubMed ID: 19565482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor gene polymorphisms, R497K, but not (CA)n repeat, is associated with dilated cardiomyopathy.
    Zhou B; Rao L; Peng Y; Zhang Q; Zhang L
    Clin Chim Acta; 2009 May; 403(1-2):184-7. PubMed ID: 19265688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.
    Ng AC; Sindone AP; Wong HS; Freedman SB
    Int J Cardiol; 2008 Sep; 129(2):198-204. PubMed ID: 17706807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]).
    Domanski M; Coady S; Fleg J; Tian X; Sachdev V
    Am J Cardiol; 2007 May; 99(10):1448-50. PubMed ID: 17493477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic polymorphism of beta-adrenergic receptors and mortality in ischemic heart disease].
    Jaillon P; Simon T
    Therapie; 2007; 62(1):1-7. PubMed ID: 17374341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single nucleotide polymorphisms in genes of circulatory homeostasis in surviving pediatric intensive care patients with meningococcal infection.
    Bunker-Wiersma HE; Koopmans RP; Kuipers TW; Knoester H; Bos AP
    Pediatr Crit Care Med; 2008 Sep; 9(5):517-23. PubMed ID: 18679149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-blockers in asymptomatic dilated cardiomyopathy: to b-block or not to b-block?
    Filippatos G; Kremastinos DT
    Eur Heart J; 2007 May; 28(9):1170-1. PubMed ID: 17412729
    [No Abstract]   [Full Text] [Related]  

  • 32. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-adrenergic blockers in congestive heart failure: pro et contra?].
    Trifunović SL; Pavlović K
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():44-50. PubMed ID: 18193810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ACE inhibitors and beta-blockers on homocysteine levels in essential hypertension.
    Poduri A; Kaur J; Thakur JS; Kumari S; Jain S; Khullar M
    J Hum Hypertens; 2008 Apr; 22(4):289-94. PubMed ID: 18200034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
    Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.
    Flannery G; Gehrig-Mills R; Billah B; Krum H
    Am J Cardiol; 2008 Mar; 101(6):865-9. PubMed ID: 18328855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.
    Jourdain P; Jondeau G; Funck F; Gueffet P; Le Helloco A; Donal E; Aupetit JF; Aumont MC; Galinier M; Eicher JC; Cohen-Solal A; Juillière Y
    J Am Coll Cardiol; 2007 Apr; 49(16):1733-9. PubMed ID: 17448376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.